Target intelligence / Profile preview

RNA polymerase subunit beta (RNAP β)

Target
RNAP β
Molecular classification
Enzyme, Polymerase, RNA polymerase core subunit
01

Overview

The **RNA polymerase subunit beta** (encoded by the **rpoB** gene) is the second largest subunit of the bacterial DNA-dependent RNA polymerase (RNAP) core enzyme. The RNAP core in bacteria comprises five subunits: two alpha (α), one beta (β), one beta prime (β’), and one omega (ω)[2][3][4][5][6][7]. The beta subunit, together with beta prime, forms the catalytic center essential for the synthesis of RNA from a DNA template during transcription[3][7]. This subunit interacts directly with both DNA and nascent RNA and provides key binding sites for transcription inhibitors, making it a major target for antibiotics such as rifampicin and other rifamycins[2][3][4][7]. Mutations in the rpoB gene, which encodes the beta subunit, are known to confer resistance to rifampicin, notably in multiple clinically relevant pathogens such as *Mycobacterium tuberculosis*, making rpoB a critical biomarker for antibiotic resistance screening[3][7]. The beta subunit is unique to bacteria, distinguishing it from eukaryotic polymerase subunits, and is regarded as an enzyme and a crucial drug target for antibacterial therapy[2][3][4][7].

Other names
RNA polymerase β subunitRNAP betaRpoB (gene name)Beta subunit of DNA-dependent RNA polymerase
02

Mechanism of action

Inhibition of RNA synthesis by binding to the beta subunit, blocking the path of the elongating RNA, preventing transcription elongation (as for rifamycins)

03

Biological functions

Transcription of DNA into RNAGene expression regulationCatalytic center for RNA synthesis
04

Disease associations

Infection (targeted by antibiotics against pathogenic bacteria)Other (antibiotic resistance marker)
05

Safety considerations

Antibiotic resistance (notably, mutations in rpoB confer rifampicin resistance)Off-target effects rare in human therapy because the target is prokaryote-specific
06

Interacting drugs

Rifampicin

4 more in the full profile.

07

Biomarkers

RpoB gene mutations as a biomarker for rifampicin resistance in *Mycobacterium tuberculosis* and other bacteria

Beyond the preview

Go deeper on RNA polymerase subunit beta (RNAP β).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase subunit beta (RNAP β).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call